Suppr超能文献

circHMGCS1 通过 miR-338-5p/IL-7 通路调节肝癌化疗耐药性。

circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR-338-5p/IL-7 pathway.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Kunming, China.

Department of Medical Oncology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.

出版信息

J Cell Mol Med. 2024 Mar;28(6):e18137. doi: 10.1111/jcmm.18137.

Abstract

Hepatocellular cancer is one of the most serious types of cancer in the world, with high incidence and mortality rates. Most HCC patients with long-term chemotherapy develop chemoresistance, leading to a poor prognosis. However, the underlying mechanism of circRNAs in HCC chemoresistance remains unclear. Our research found that circ_0072391(circ_HMGCS1) expression was significantly upregulated in cisplatin-resistant HCC cells. The silence of circ_HMGCS1 attenuated the cisplatin resistance in HCC. Results showed that circ_HMGCS1 regulated the expression of miR-338-5p via acting as microRNA sponges. Further study confirmed that miR-338-5p regulated the expression of IL-7. IL-7 could remodel the immune system by improving T-cell function and antagonising the immunosuppressive network. IL-7 is an ideal target used to enhance the function of the immune system. circ_HMGCS1 exerts its oncogenic function through the miR-338-5p/IL-7 pathway. Inhibition of circ_HMGCS1/miR-338-5p/IL-7 could effectively attenuate the chemoresistance of HCC. IL-7 might be a promising immunotherapy target for HCC cancer treatment.

摘要

肝细胞癌是世界上最严重的癌症类型之一,具有发病率和死亡率高的特点。大多数长期接受化疗的 HCC 患者会产生化疗耐药性,导致预后不良。然而,circRNAs 在 HCC 化疗耐药性中的潜在机制尚不清楚。我们的研究发现,circ_0072391(circ_HMGCS1)在顺铂耐药 HCC 细胞中表达显著上调。circ_HMGCS1 的沉默减弱了 HCC 对顺铂的耐药性。结果表明,circ_HMGCS1 通过充当 microRNA 海绵来调节 miR-338-5p 的表达。进一步的研究证实,miR-338-5p 调节了 IL-7 的表达。IL-7 通过改善 T 细胞功能和拮抗免疫抑制网络来重塑免疫系统。IL-7 是增强免疫系统功能的理想靶点。circ_HMGCS1 通过 miR-338-5p/IL-7 通路发挥致癌作用。抑制 circ_HMGCS1/miR-338-5p/IL-7 可有效减弱 HCC 的化疗耐药性。IL-7 可能是 HCC 癌症治疗的一种有前途的免疫治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb11/10915820/fb21b29def14/JCMM-28-e18137-g004.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验